+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Combined low-dose zearalenone and aflatoxin B1 on cell growth and cell-cycle progression in breast cancer MCF-7 cells



Combined low-dose zearalenone and aflatoxin B1 on cell growth and cell-cycle progression in breast cancer MCF-7 cells



Toxicology Letters 281: 139-151



Zearalenone (ZEA) has long been recognized as a xenoestrogen, while the endocrine disrupting effects of aflatoxin B1 (AFB1) have been identified recently. Due to co-occurrence and endocrine disrupting potentials of ZEA and AFB1, it was hypothesized that co-exposure to ZEA and AFB1 might affect breast cancer cell growth. Consequently, the aim of this study was to evaluate the combined effects of ZEA and AFB1 (1nM-100nM) on cell growth and cell cycle progression, using a human breast cancer cell line MCF-7. Our results showed that ZEA and AFB1 produced significant interactive effects on cell growth, DNA synthesis and cell cycle progression. While ZEA promoted growth, DNA synthesis and cell cycle progression, AFB1 was cytotoxic and counteracted the effects of ZEA. ZEA altered the expression of several breast cancer related genes, whereas AFB1 had minimal effects on gene expression. With the use of specific inhibitors, ERα, GPER and MAPK pathways were found to be responsible for ZEA's effects on cell growth; while MAPK pathways might be involved in cytotoxic effects by AFB1. This study is first to report the effects of co-exposure of ZEA and AFB1 on breast cancer cell growth, possibly through ER dependent pathway. This suggested that endocrine-disrupting mycotoxins that co-occur in human food can interact and influence human health. Future work on interactive effects of endocrine-disrupting mycotoxins or other xenoestrogens is warranted, which will contribute to improved risk assessments.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059520456

Download citation: RISBibTeXText

PMID: 28965971

DOI: 10.1016/j.toxlet.2017.09.022


Related references

Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B. European Journal of Pharmacology 680(1-3): 8-15, 2012

Fibroblast growth factor 8 increases breast cancer cell growth by promoting cell cycle progression and by protecting against cell death. Experimental Cell Research 316(5): 800-812, 2010

Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines. Nutrition and Cancer 32(1): 1-7, 1998

Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. Cell Growth & Differentiation 7(1): 65-74, 1996

CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation. Molecular Cancer Research 17(2): 604-617, 2019

Effects of estradiol metabolites on MCF-7 breast cancer cell growth and cell cycle progression. Proceedings of the American Association for Cancer Research Annual Meeting 40: 160, 1999

Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells. Cancer Research 64(7): 2509-2515, 2004

PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo. Drug Design Development and Therapy 9: 4631-4638, 2015

The effects of beta-estradiol on Raf activity, cell cycle progression and growth factor synthesis in the MCF-7 breast cancer cell line. Cancer Biology and Therapy 1(3): 256-262, 2002

ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells. Biochimica et Biophysica Acta 1833(3): 752-760, 2013

Effect of autophagy inhibition on cell viability and cell cycle progression in MDA‑MB‑231 human breast cancer cells. Molecular Medicine Reports 10(2): 625-630, 2014

Suppression of cell growth, cell cycle progression, and induction of apoptosis by aromatase inhibitors in aromatase-expressing MCF-7Ca human breast cancer cell line. Proceedings of the American Association for Cancer Research Annual Meeting 42: 236, 2001

Ectopic expression of PTEN negatively regulates both cell cycle progression and cell survival in breast cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting (41): 201, 2000

Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells. Toxicology and Applied Pharmacology 366: 75-82, 2019

The SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis. Endocrinology 155(9): 3251-3261, 2014